Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Jan;96(1):83–90. doi: 10.1111/j.1476-5381.1989.tb11787.x

The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs.

W Feniuk 1, P P Humphrey 1, M J Perren 1
PMCID: PMC1854323  PMID: 2538184

Abstract

1. GR43175 is a highly selective agonist at 5-HT1-like receptors in the dog saphenous vein. This study describes the haemodynamic effects of GR43175 in barbitone-anaesthetized dogs. 2. GR43175 (1-1000 micrograms kg-1, i.v.) produced dose-dependent decreases in carotid arterial blood flow with little or no change in arterial blood pressure. The decrease in blood flow was associated with an increase in carotid arterial vascular resistance. In preliminary studies, the dose of GR43175 producing 50% of the maximum carotid vasoconstrictor response was 39 +/- 8 micrograms kg-1, i.v. 3. In comparative regional haemodynamic studies, GR43175 (1-1000 micrograms kg-1, i.v.) had little effect on total peripheral resistance or resistance in the mesenteric, vertebral and coronary arterial vascular beds. Low doses of GR43175 decreased, whilst high doses (100 micrograms kg-1, i.v. and above) increased femoral arterial vascular resistance. GR43175 (1-1000 micrograms kg-1, i.v.) had no effect on respiratory inflation pressure. In doses of 100 micrograms kg-1 i.v. and above, GR43175 caused small decreases in heart rate. 4. The carotid arterial vasoconstrictor action of GR43175 was resistant to antagonism by the 5-HT2 receptor, 5-HT3 receptor and alpha-adrenoceptor blocking drugs, ketanserin, MDL72222 and phentolamine respectively, but could be antagonized by the non-selective 5-HT1-like receptor blocking drug methiothepin. Methiothepin had no effect on the carotid vasoconstrictor action of the thromboxane A2 mimetic, U46619. 5. The results demonstrate that GR43175 produces a selective vasoconstriction in the carotid arterial circulation of anaesthetized dogs via activation of 5-HT1-like receptors, which appear similar to those mediating contraction of the dog isolated saphenous vein.

Full text

PDF
83

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apperley E., Feniuk W., Humphrey P. P., Levy G. P. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol. 1980 Feb;68(2):215–224. doi: 10.1111/j.1476-5381.1980.tb10410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Apperley E., Humphrey P. P., Levy G. P. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol. 1976 Oct;58(2):211–221. doi: 10.1111/j.1476-5381.1976.tb10398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coote J. H., Dalton D. W., Fenuik W., Humphrey P. P. The central site of the sympatho-inhibitory action of 5-hydroxytryptamine in the cat. Neuropharmacology. 1987 Feb-Mar;26(2-3):147–154. doi: 10.1016/0028-3908(87)90202-4. [DOI] [PubMed] [Google Scholar]
  4. Delaney J., Scarpino J. Limb arteriovenous shunting following sympathetic denervation. Surgery. 1973 Feb;73(2):202–206. [PubMed] [Google Scholar]
  5. Doenicke A., Brand J., Perrin V. L. Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet. 1988 Jun 11;1(8598):1309–1311. doi: 10.1016/s0140-6736(88)92122-8. [DOI] [PubMed] [Google Scholar]
  6. Feniuk W., Humphrey P. P., Watts A. D. Modification of the vasomotor actions of methysergide in the femoral arterial bed of the anaesthetized dog by changes in sympathetic nerve activity. J Auton Pharmacol. 1981 Mar;1(2):127–132. doi: 10.1111/j.1474-8673.1981.tb00504.x. [DOI] [PubMed] [Google Scholar]
  7. Humphrey P. P., Feniuk W., Perren M. J., Connor H. E., Oxford A. W., Coates L. H., Butina D. GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol. 1988 Aug;94(4):1123–1132. doi: 10.1111/j.1476-5381.1988.tb11630.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jandhyala B. S., Kivlighn S. D. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb. Fed Proc. 1987 Feb;46(2):276–280. [PubMed] [Google Scholar]
  9. Saxena P. R., Koedam N. A., Heiligers J., Hof R. P. Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia. 1983 Jun;3(2):71–81. doi: 10.1046/j.1468-2982.1983.0302071.x. [DOI] [PubMed] [Google Scholar]
  10. Saxena P. R. Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol. 1974 Jun;27(1):99–105. doi: 10.1016/0014-2999(74)90206-4. [DOI] [PubMed] [Google Scholar]
  11. Saxena P. R., de Vlaam-Schluter G. M. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine. Headache. 1974 Jan;13(4):142–163. doi: 10.1111/j.1526-4610.1974.hed1304142.x. [DOI] [PubMed] [Google Scholar]
  12. Watts A. D., Feniuk W., Humphrey P. P. A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein. J Pharm Pharmacol. 1981 Aug;33(8):515–520. doi: 10.1111/j.2042-7158.1981.tb13850.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES